Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v8-FR | Version v2-FR | |
|---|---|---|
| Language | French | French |
| Date Updated | 2023-09-14 | 2023-07-20 |
| Drug Identification Number | 02194465 | 02194465 |
| Brand name | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP |
| Common or Proper name | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP | DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP |
| Company Name | PFIZER CANADA ULC | PFIZER CANADA ULC |
| Ingredients | DOXORUBICIN HYDROCHLORIDE | DOXORUBICIN HYDROCHLORIDE |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION | POWDER FOR SOLUTION |
| Route of administration | INTRAVESICAL INTRAVENOUS INTRAVESICAL INTRAVENOUS | INTRAVESICAL INTRAVENOUS INTRAVESICAL INTRAVENOUS |
| Packaging size | 25mL vial | 25mL vial |
| ATC code | L01DB | L01DB |
| ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | 2023-08-31 | 2023-08-04 |
| Actual start date | ||
| Estimated end date | 2023-09-11 | |
| Actual end date | 2023-09-11 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |